Form Attachment #7 Attachment #7 Laboratory Information Change Form

26968

Federal Register / Vol. 71, No. 89 / Tuesday, May 9, 2006 / Notices

Additionally, we are currently

accepting applications for FY2005 grant

cycle and will do so until July 31, 2006

or until all FY2005 funding has been

obligated. Please consult the FMCS Web

site (http://www.fmcs.gov) to download

forms and information.

Fran Leonard,

Director, Budget and Finance, Federal

Mediation and Conciliation Service.

[FR Doc. E6–7034 Filed 5–8–06; 8:45 am]

BILLING CODE 6732–01–P

FEDERAL RESERVE SYSTEM

Change in Bank Control Notices;

Acquisition of Shares of Bank or Bank

Holding Companies

The notificants listed below have

applied under the Change in Bank

Control Act (12 U.S.C. 1817(j)) and

§ 225.41 of the Board’s Regulation Y (12

CFR 225.41) to acquire a bank or bank

holding company. The factors that are

considered in acting on the notices are

set forth in paragraph 7 of the Act (12

U.S.C. 1817(j)(7)).

The notices are available for

immediate inspection at the Federal

Reserve Bank indicated. The notices

also will be available for inspection at

the office of the Board of Governors.

Interested persons may express their

views in writing to the Reserve Bank

indicated for that notice or to the offices

of the Board of Governors. Comments

must be received not later than May 24,

2006.

A. Federal Reserve Bank of Atlanta

(Andre Anderson, Vice President) 1000

Peachtree Street, NE., Atlanta, Georgia

30309:

1. Charles H. Roland and Kimberly O.

Roland, Andalusia, Alabama; to retain

voting shares of Southern National

Corporation, Andalusia, Alabama, and

thereby indirectly retain voting shares of

Covington County Bank, Andalusia,

Alabama.

B. Federal Reserve Bank of Chicago

(Patrick M. Wilder, Assistant Vice

President) 230 South LaSalle Street,

Chicago, Illinois 60690-1414:

1. Harold Dean Westra, individually

and acting in concert with Greg Todd

Westra, both of Rock Valley, Iowa; to

acquire voting shares of Premier

Holdings, Ltd., Rock Valley, Iowa, and

thereby indirectly acquire voting shares

of Premier Bank, Rock Valley, Iowa.

C. Federal Reserve Bank of St. Louis

(Glenda Wilson, Community Affairs

Officer) 411 Locust Street, St. Louis,

Missouri 63166-2034:

1. J. Chester Porter, Shepherdsville,

Kentucky, and the William G. Porter

Revocable Trust, Sarasota, Florida; to

acquire voting shares of Porter Bancorp,

Inc., Shepherdsville, Kentucky, and

thereby indirectly acquire voting shares

of PBI Bank, Greensburg, Kentucky.

Board of Governors of the Federal Reserve

System, May 4, 2006.

Robert deV. Frierson,

Deputy Secretary of the Board.

[FR Doc. E6–6994 Filed 5–8–06; 8:45 am]

BILLING CODE 6210–01–S

FEDERAL RESERVE SYSTEM

Formations of, Acquisitions by, and

Mergers of Bank Holding Companies

The companies listed in this notice

have applied to the Board for approval,

pursuant to the Bank Holding Company

Act of 1956 (12 U.S.C. 1841 et seq.)

(BHC Act), Regulation Y (12 CFR part

225), and all other applicable statutes

and regulations to become a bank

holding company and/or to acquire the

assets or the ownership of, control of, or

the power to vote shares of a bank or

bank holding company and all of the

banks and nonbanking companies

owned by the bank holding company,

including the companies listed below.

The applications listed below, as well

as other related filings required by the

Board, are available for immediate

inspection at the Federal Reserve Bank

indicated. The application also will be

available for inspection at the offices of

the Board of Governors. Interested

persons may express their views in

writing on the standards enumerated in

the BHC Act (12 U.S.C. 1842(c)). If the

proposal also involves the acquisition of

a nonbanking company, the review also

includes whether the acquisition of the

nonbanking company complies with the

standards in section 4 of the BHC Act

(12 U.S.C. 1843). Unless otherwise

noted, nonbanking activities will be

conducted throughout the United States.

Additional information on all bank

holding companies may be obtained

from the National Information Center

Web site at http://www.ffiec.gov/nic/.

Unless otherwise noted, comments

regarding each of these applications

must be received at the Reserve Bank

indicated or the offices of the Board of

Governors not later than June 2, 2006.

A. Federal Reserve Bank of Atlanta

(Andre Anderson, Vice President) 1000

Peachtree Street, N.E., Atlanta, Georgia

30309:

1. Great Financial Corporation, Miami

Lakes, Florida; to become a bank

holding company by acquiring 100

percent of the voting shares of Great

Florida Bank, Miami, Florida.

B. Federal Reserve Bank of Kansas

City (Donna J. Ward, Assistant Vice

President) 925 Grand Avenue, Kansas

City, Missouri 64198-0001:

1. BancFirst Corporation, Oklahoma

City, Oklahoma; to acquire 100 percent

of the voting shares of First Bartlesville

Bank, Bartlesville, Oklahoma.

Board of Governors of the Federal Reserve

System, May 4, 2006.

Robert deV. Frierson,

Deputy Secretary of the Board.

[FR Doc. E6–6993 Filed 5–8–06; 8:45 am]

BILLING CODE 6210–01–S

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[60 Day–06–0600]

Proposed Data Collections Submitted

for Public Comment and

Recommendations

In compliance with the requirement

of Section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995 for

opportunity for public comment on

proposed data collection projects, the

Centers for Disease Control and

Prevention (CDC) will publish periodic

summaries of proposed projects. To

request more information on the

proposed projects or to obtain a copy of

the data collection plans and

instruments, call 404–639–5960 and

send comments to Seleda Perryman,

CDC Assistant Reports Clearance

Officer, 1600 Clifton Road, MS–D74,

Atlanta, GA 30333 or send an e-mail to

omb@cdc.gov.

Comments are invited on: (a) Whether

the proposed collection of information

is necessary for the proper performance

of the functions of the agency, including

whether the information shall have

practical utility; (b) the accuracy of the

agency’s estimate of the burden of the

proposed collection of information; (c)

ways to enhance the quality, utility, and

clarity of the information to be

collected; and (d) ways to minimize the

burden of the collection of information

on respondents, including through the

use of automated collection techniques

or other forms of information

technology. Written comments should

be received within 60 days of this

notice.

Proposed Project

Performance Evaluation Program for

Mycobacterium Tuberculosis and Non-

VerDate Aug<31>2005

15:42 May 08, 2006

Jkt 208001

PO 00000

Frm 00049

Fmt 4703

Sfmt 4703

E:\FR\FM\09MYN1.SGM 09MYN1

mstockstill on PROD1PC68 with NOTICES

26969

Federal Register / Vol. 71, No. 89 / Tuesday, May 9, 2006 / Notices

Tuberculous Mycobacterium (NTM)

Drug Susceptibility Testing (0920–

0600)—Extension—National Center for

Health Marketing (NCHM), Coordinating

Center for Health Information and

Service (CoCHIS), Centers for Disease

Control and Prevention (CDC).

Background and Brief Description

As part of the continuing effort to

support both domestic and global public

health objectives for treatment of

tuberculosis (TB), prevention of multi-

drug resistance and surveillance

programs, the Division of Laboratory

Systems seeks to continue to collect

information from domestic private

clinical and public health laboratories

twice per year. Participation and

information collections from

international laboratories are limited to

those which have public health

responsibilities for tuberculosis drug

susceptibility testing and approval by

their national tuberculosis program.

While the overall number of cases of TB

in the U.S. has decreased, rates still

remain high among foreign-born

persons, prisoners, homeless

populations, and individuals infected

with HIV in major metropolitan areas.

The rate of TB cases detected in foreign-

born persons has been reported to be

almost nine times higher than the rate

among the U.S. born population.

CDC’s goal to eliminate TB will be

virtually impossible without

considerable effort in assisting countries

with heavy disease burden in the

reduction of tuberculosis. The

M.tuberculosis/NTM program supports

this role by monitoring the level of

performance and practices among

laboratories performing M. tuberculosis

susceptibility within the U.S, as well as

internationally, to ensure high-quality

laboratory testing, resulting in accurate

and reliable results.

Information collected in this program

includes the susceptibility test results of

primary and secondary drugs,

concentrations, and test methods

performed by laboratories on a set of

challenge isolates sent twice yearly. A

portion of the response instrument

collects demographic data such as

laboratory type and the number of tests

performed annually. By providing an

evaluation program to assess the ability

of the laboratories to test for drug

resistant M. tuberculosis and selected

strains of NTM, laboratories have a self-

assessment tool to aid in maximizing

their skills in susceptibility testing.

Information obtained from laboratories

on susceptibility testing practices and

procedures assists with determining

variables related to good performance,

with assessing areas for training and

with developing practice standards.

There are no cost to the respondents

other than their time.

E

STIMATED

A

NNUALIZED

B

URDEN

H

OURS

Respondents

No. of re-

spondents

Average num-

ber of re-

sponses per

respondent

Average bur-

den per re-

sponse

(in hours)

Total burden

hours

Domestic Private/Public Laboratories ..............................................................

165

1

30/60

83

International Laboratories (with public health responsibilities) ........................

165

1

30/60

83

Total

..........................................................................................................

........................

........................

........................

166

Dated: May 1, 2006.

Joan F. Karr,

Acting Reports Clearance Officer, Centers for

Disease Control and Prevention.

[FR Doc. E6–7002 Filed 5–8–06; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[60Day–06–0469]

Proposed Data Collections Submitted

for Public Comment and

Recommendations

In compliance with the requirement

of Section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995 for

opportunity for public comment on

proposed data collection projects, the

Centers for Disease Control and

Prevention (CDC) will publish periodic

summaries of proposed projects. To

request more information on the

proposed projects or to obtain a copy of

the data collection plans and

instruments, call 404–639–5960 and

send comments to Seleda Perryman,

CDC Assistant Reports Clearance

Officer, 1600 Clifton Road, MS–D74,

Atlanta, GA 30333 or send an e-mail to

omb@cdc.gov.

Comments are invited on: (a) Whether

the proposed collection of information

is necessary for the proper performance

of the functions of the agency, including

whether the information shall have

practical utility; (b) the accuracy of the

agency’s estimate of the burden of the

proposed collection of information; (c)

ways to enhance the quality, utility, and

clarity of the information to be

collected; and (d) ways to minimize the

burden of the collection of information

on respondents, including through the

use of automated collection techniques

or other forms of information

technology. Written comments should

be received within 60 days of this

notice.

Proposed Project

National Program of Cancer

Registries—Cancer Surveillance

System—Extension (OMB number

0920–0469)—National Center for

Chronic Disease Prevention and Health

Promotion (NCCDPHP), Centers for

Disease Control and Prevention (CDC).

Background and Brief Description

The American Cancer Society

estimated that about 1.37 million

Americans were newly diagnosed with

cancer in 2005 and that about 570,000

died from cancer in that same year. The

National Institutes of Health estimates

that in 2005, the cost of cancer was

about $209 billion, including $74 billion

direct costs to treat cancer, and $136

billion indirect costs in lost productivity

due to illness and premature death.

In 2002, CDC implemented the

National Program of Cancer Registries

(NPCR)—Cancer Surveillance System

(CSS) to collect, evaluate and

disseminate cancer incidence data

collected by population-based cancer

registries. In 2002, CDC began annually

publishing United States Cancer

Statistics (USCS). The latest USCS

report published in 2005 provided

cancer statistics for 93% of the United

States population from all cancer

registries whose data met national data

standards. Prior to the publication of

USCS, at the national level, cancer

incidence data were available for only

14% of the population of the United

States.

With this expanded coverage of the

U.S. population, it will now be possible

VerDate Aug<31>2005

15:42 May 08, 2006

Jkt 208001

PO 00000

Frm 00050

Fmt 4703

Sfmt 4703

E:\FR\FM\09MYN1.SGM 09MYN1

mstockstill on PROD1PC68 with NOTICES